K. Kok

Fabry Disease: Molecular Basis, Pathophysiology, Diagnostics and Potential Therapeutic Directions

M. Artola, H. Overkleeft, R. Boot, 2021, Biomolecules.

1,6-epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease

H. Overkleeft, M. Artola, G. Sulzenbacher, 2022, Journal of the American Chemical Society.